Literature DB >> 21297265

Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease.

Stephen W Scheff1, Douglas A Price, Frederick A Schmitt, Melissa A Scheff, Elliott J Mufson.   

Abstract

Alzheimer's disease (AD) is a slowly progressing form of dementia characterized in its earliest stages as a loss of memory. Individuals with amnestic mild cognitive impairment (aMCI) may be in the earliest stages of the disease and represent an opportunity to identify pathological changes related to the progression of AD. Synaptic loss is one of the hallmarks of AD and associated with cognitive impairment. The inferior temporal gyrus plays an important role in verbal fluency, a cognitive function affected early in the onset of AD. Unbiased stereology coupled with electron microscopy was used to quantify total synaptic numbers in lamina 3 of the inferior temporal gyrus from short postmortem autopsy tissue harvested from subjects who died at different cognitive stages during the progression of AD. Individuals with aMCI had significantly fewer synapses (36%) compared to individuals with no cognitive impairment. Individuals with AD showed a loss of synapses very similar to the aMCI cohort. Synaptic numbers correlated highly with Mini Mental State Examination scores and a test of category verbal fluency. These results demonstrate that the inferior temporal gyrus is affected during the prodromal stage of the disease and may underlie some of the early AD-related clinical dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297265      PMCID: PMC3098316          DOI: 10.3233/JAD-2011-101782

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  66 in total

1.  Marked loss of myelinated nerve fibers in the human brain with age.

Authors:  Lisbeth Marner; Jens R Nyengaard; Yong Tang; Bente Pakkenberg
Journal:  J Comp Neurol       Date:  2003-07-21       Impact factor: 3.215

2.  Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.

Authors:  Rudi K Tannenberg; Heather L Scott; Anthony E G Tannenberg; Peter R Dodd
Journal:  Neurochem Int       Date:  2006-06-30       Impact factor: 3.921

3.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

4.  Quantitative synaptic alterations in the human neocortex during normal aging.

Authors:  E Masliah; M Mallory; L Hansen; R DeTeresa; R D Terry
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

5.  Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents.

Authors:  W A Suzuki; D G Amaral
Journal:  J Comp Neurol       Date:  1994-12-22       Impact factor: 3.215

6.  Inferotemporal lesions and memory for pattern discriminations after visual interference.

Authors:  P Dean; A Cowey
Journal:  Neuropsychologia       Date:  1977       Impact factor: 3.139

Review 7.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 8.  Structural correlates of cognition in dementia: quantification and assessment of synapse change.

Authors:  S T DeKosky; S W Scheff; S D Styren
Journal:  Neurodegeneration       Date:  1996-12

9.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

10.  Converging language streams in the human temporal lobe.

Authors:  Galina Spitsyna; Jane E Warren; Sophie K Scott; Federico E Turkheimer; Richard J S Wise
Journal:  J Neurosci       Date:  2006-07-12       Impact factor: 6.167

View more
  93 in total

1.  Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.

Authors:  Xiaohua Deng; Meili Li; Weiming Ai; Lixin He; Dahua Lu; Peter R Patrylo; Huaibin Cai; Xuegang Luo; Zhiyuan Li; Xiaoxin Yan
Journal:  Adv Alzheimer Dis       Date:  2014-06

Review 2.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

3.  7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease.

Authors:  Zhentao Zhang; Xia Liu; Jason P Schroeder; Chi-Bun Chan; Mingke Song; Shan Ping Yu; David Weinshenker; Keqiang Ye
Journal:  Neuropsychopharmacology       Date:  2013-09-11       Impact factor: 7.853

Review 4.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

5.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 6.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

7.  Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Mubeen A Ansari; Kelly N Roberts; Frederick A Schmitt; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Effect of leukocyte telomere length on total and regional brain volumes in a large population-based cohort.

Authors:  Kevin S King; Julia Kozlitina; Roger N Rosenberg; Ronald M Peshock; Roderick W McColl; Christine K Garcia
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

Review 9.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

10.  Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Kelly N Roberts; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.